spacer
spacer
Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Receptor PDB id
1a52
Jmol
Contents
Protein chains
239 a.a. *
Ligands
EST ×2
Metals
_AU ×6
Waters ×30
* Residue conservation analysis
PDB id:
1a52
Name: Receptor
Title: Estrogen receptor alpha ligand-binding domain complexed to e
Structure: Estrogen receptor. Chain: a, b. Fragment: ligand-binding domain. Synonym: erlbd. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Cell_line: bl21. Gene: esr. Expressed in: escherichia coli. Expression_system_taxid: 562.
Biol. unit: Dimer (from PDB file)
Resolution:
2.80Å     R-factor:   0.223     R-free:   0.274
Authors: D.M.Tanenbaum,Y.Wang,P.B.Sigler
Key ref:
D.M.Tanenbaum et al. (1998). Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci U S A, 95, 5998-6003. PubMed id: 9600906 DOI: 10.1073/pnas.95.11.5998
Date:
19-Feb-98     Release date:   16-Sep-98    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P03372  (ESR1_HUMAN) -  Estrogen receptor
Seq:
Struc:
 
Seq:
Struc:
595 a.a.
239 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     nucleus   1 term 
  Biological process     steroid hormone mediated signaling pathway   2 terms 
  Biochemical function     DNA binding     3 terms  

 

 
DOI no: 10.1073/pnas.95.11.5998 Proc Natl Acad Sci U S A 95:5998-6003 (1998)
PubMed id: 9600906  
 
 
Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains.
D.M.Tanenbaum, Y.Wang, S.P.Williams, P.B.Sigler.
 
  ABSTRACT  
 
The 2.8-A crystal structure of the complex formed by estradiol and the human estrogen receptor-alpha ligand binding domain (hERalphaLBD) is described and compared with the recently reported structure of the progesterone complex of the human progesterone receptor ligand binding domain, as well as with similar structures of steroid/nuclear receptor LBDs solved elsewhere. The hormone-bound hERalphaLBD forms a distinctly different and probably more physiologically important dimer interface than its progesterone counterpart. A comparison of the specificity determinants of hormone binding reveals a common structural theme of mutually supported van der Waals and hydrogen-bonded interactions involving highly conserved residues. The previously suggested mechanism by which the estrogen receptor distinguishes estradiol's unique 3-hydroxy group from the 3-keto function of most other steroids is now described in atomic detail. Mapping of mutagenesis results points to a coactivator-binding surface that includes the region around the "signature sequence" as well as helix 12, where the ligand-dependent conformation of the activation function 2 core is similar in all previously solved steroid/nuclear receptor LBDs. A peculiar crystal packing event displaces helix 12 in the hERalphaLBD reported here, suggesting a higher degree of dynamic variability than expected for this critical substructure.
 
  Selected figure(s)  
 
Figure 2.
Fig. 2. Arrangement of hER LBDs in the crystal structure. (A) The tetramer formed by the intermolecular disulfide bonds between Cys-530 of neighboring hER LBD molecules and dimerization around the local dyad. (Inset) A schematization of the arrangement. Positions of the disulfides are marked with a yellow disc with red "S." Red symbols in the center of the tetramer and schematic show the crystallographic dyad, and the red arrow in the inset indicates the noncrystallographic symmetry dyad. (B) Comparison of the dimers of holo-hER LBD, apo-hRXR LBD, and holo-hPRLBD viewed down the local dyad (17, 18). The dimer interfaces of holo-hER LBD and apo-hRXR LBD are similar, with helices 7-10 as the major contributors. The holo-hPRLBD dimer interface is substantially different, composed predominantly of helices 11 and 12, as well as the extreme C-terminal tail. Drawn with RIBBONS (29).
Figure 3.
Fig. 3. Specificity determinants of the hormone-binding site specifies 3-hydroxy vs. 3-keto steroids. (A) The hydrogen-bonding network as seen in the hER LBD and hPRLBD (18). The discriminating relationship of Glu/Gln to the 3-hydroxy/keto of the steroid is supported by a network of water-mediated hydrogen bonds involving the side chain of a conserved Arg and backbone carbonyl of a conserved Phe that, in turn, are fixed by hydrophobic contacts with the steroid ring. Note that the PR has no obvious hydrogen bonding discrimination at the 20-keto position of progesterone comparable to the hydrogen-bonding interaction seen between the 17-hydroxyl of estradiol and His-524. (B) Space-filling representation of estradiol in the ligand-binding pocket of hER LBD and progesterone in the ligand-binding pocket of hPRLBD (18). For the proteins, carbon atoms are gray, oxygen atoms red, sulfur atoms yellow and nitrogen atoms blue. For the hormones, carbon atoms are cyan, oxygen atoms magenta. Drawn with MIDAS (36). (C) Schematic of estradiol in the hER LBD ligand-binding pocket in the structure shown here; hormone (red) rings are lettered, and carbon atoms are numbered. Residues hydrogen bonded directly to the hormone are blue. Dashed lines indicate hydrophobic van der Waals contacts with the hormone. Residues conserved among the steroid receptors are green, and variable residues are black. Residues contributed by helix 12 (1) are not shown.
 
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21334935 W.De-Eknamkul, K.Umehara, O.Monthakantirat, R.Toth, V.Frecer, L.Knapic, P.Braiuca, H.Noguchi, and S.Miertus (2011).
QSAR study of natural estrogen-like isoflavonoids and diphenolics from Thai medicinal plants.
  J Mol Graph Model, 29, 784-794.  
21069581 Y.Huang, X.Li, and M.Muyan (2011).
Estrogen receptors similarly mediate the effects of 17β-estradiol on cellular responses but differ in their potencies.
  Endocrine, 39, 48-61.  
20096719 J.Kelder, R.Azevedo, Y.Pang, J.de Vlieg, J.Dong, and P.Thomas (2010).
Comparison between steroid binding to membrane progesterone receptor alpha (mPRalpha) and to nuclear progesterone receptor: correlation with physicochemical properties assessed by comparative molecular field analysis and identification of mPRalpha-specific agonists.
  Steroids, 75, 314-322.  
19818358 N.C.Nicolaides, Z.Galata, T.Kino, G.P.Chrousos, and E.Charmandari (2010).
The human glucocorticoid receptor: molecular basis of biologic function.
  Steroids, 75, 1.  
20148675 P.Huang, V.Chandra, and F.Rastinejad (2010).
Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics.
  Annu Rev Physiol, 72, 247-272.  
20817759 R.Goyanka, S.Das, H.H.Samuels, and T.Cardozo (2010).
Nuclear receptor engineering based on novel structure activity relationships revealed by farnesyl pyrophosphate.
  Protein Eng Des Sel, 23, 809-815.  
19362102 C.Byrne, S.D.Divekar, G.B.Storchan, D.A.Parodi, and M.B.Martin (2009).
Cadmium--a metallohormone?
  Toxicol Appl Pharmacol, 238, 266-271.  
19881910 C.M.Klinge (2009).
Estrogen Regulation of MicroRNA Expression.
  Curr Genomics, 10, 169-183.  
19666591 H.Ogawa, T.Shinoda, F.Cornelius, and C.Toyoshima (2009).
Crystal structure of the sodium-potassium pump (Na+,K+-ATPase) with bound potassium and ouabain.
  Proc Natl Acad Sci U S A, 106, 13742-13747.
PDB code: 3a3y
19723634 H.Pick, S.Etter, O.Baud, R.Schmauder, L.Bordoli, T.Schwede, and H.Vogel (2009).
Dual activities of odorants on olfactory and nuclear hormone receptors.
  J Biol Chem, 284, 30547-30555.  
19557178 M.E.Baker, D.J.Chang, and C.Chandsawangbhuwana (2009).
3D model of lamprey estrogen receptor with estradiol and 15alpha-hydroxy-estradiol.
  PLoS One, 4, e6038.  
19207820 M.J.Tetel (2009).
Nuclear receptor coactivators: essential players for steroid hormone action in the brain and in behaviour.
  J Neuroendocrinol, 21, 229-237.  
19401208 M.J.Tetel, A.P.Auger, and T.D.Charlier (2009).
Who's in charge? Nuclear receptor coactivator and corepressor function in brain and behavior.
  Front Neuroendocrinol, 30, 328-342.  
19430488 M.K.Dennis, R.Burai, C.Ramesh, W.K.Petrie, S.N.Alcon, T.K.Nayak, C.G.Bologa, A.Leitao, E.Brailoiu, E.Deliu, N.J.Dun, L.A.Sklar, H.J.Hathaway, J.B.Arterburn, T.I.Oprea, and E.R.Prossnitz (2009).
In vivo effects of a GPR30 antagonist.
  Nat Chem Biol, 5, 421-427.  
19702782 P.Li, A.K.Bandyopadhyaya, D.F.Covey, J.H.Steinbach, and G.Akk (2009).
Hydrogen bonding between the 17beta-substituent of a neurosteroid and the GABA(A) receptor is not obligatory for channel potentiation.
  Br J Pharmacol, 158, 1322-1329.  
19666041 R.Kumar, and G.Litwack (2009).
Structural and functional relationships of the steroid hormone receptors' N-terminal transactivation domain.
  Steroids, 74, 877-883.  
19333551 S.Ellmann, H.Sticht, F.Thiel, M.W.Beckmann, R.Strick, and P.L.Strissel (2009).
Estrogen and progesterone receptors: from molecular structures to clinical targets.
  Cell Mol Life Sci, 66, 2405-2426.  
19633971 T.Kino, Y.A.Su, and G.P.Chrousos (2009).
Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology.
  Cell Mol Life Sci, 66, 3435-3448.  
18492816 D.Pugazhendhi, K.A.Watson, S.Mills, N.Botting, G.S.Pope, and P.D.Darbre (2008).
Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells.
  J Endocrinol, 197, 503-515.  
18787702 J.T.Bridgham, J.E.Brown, A.Rodríguez-Marí, J.M.Catchen, and J.W.Thornton (2008).
Evolution of a new function by degenerative mutation in cephalochordate steroid receptors.
  PLoS Genet, 4, e1000191.  
18655705 M.Paris, K.Pettersson, M.Schubert, S.Bertrand, I.Pongratz, H.Escriva, and V.Laudet (2008).
An amphioxus orthologue of the estrogen receptor that does not bind estradiol: insights into estrogen receptor evolution.
  BMC Evol Biol, 8, 219.  
18815806 M.Schubert, F.Brunet, M.Paris, S.Bertrand, G.Benoit, and V.Laudet (2008).
Nuclear hormone receptor signaling in amphioxus.
  Dev Genes Evol, 218, 651-665.  
  19079612 R.Narayanan, M.L.Mohler, C.E.Bohl, D.D.Miller, and J.T.Dalton (2008).
Selective androgen receptor modulators in preclinical and clinical development.
  Nucl Recept Signal, 6, e010.  
18330543 T.Harada, K.Yamagishi, T.Nakano, K.Kitaura, and H.Tokiwa (2008).
Ab initio fragment molecular orbital study of ligand binding to human progesterone receptor ligand-binding domain.
  Naunyn Schmiedebergs Arch Pharmacol, 377, 607-615.  
  18097104 V.Cura, M.Gangloff, S.Eiler, D.Moras, and M.Ruff (2008).
Cleaved thioredoxin fusion protein enables the crystallization of poorly soluble ERalpha in complex with synthetic ligands.
  Acta Crystallogr Sect F Struct Biol Cryst Commun, 64, 54-57.  
17164529 A.M.Hassell, G.An, R.K.Bledsoe, J.M.Bynum, H.L.Carter, S.J.Deng, R.T.Gampe, T.E.Grisard, K.P.Madauss, R.T.Nolte, W.J.Rocque, L.Wang, K.L.Weaver, S.P.Williams, G.B.Wisely, R.Xu, and L.M.Shewchuk (2007).
Crystallization of protein-ligand complexes.
  Acta Crystallogr D Biol Crystallogr, 63, 72-79.  
17392432 C.M.Eakin, M.J.Maccoss, G.L.Finney, and R.E.Klevit (2007).
Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.
  Proc Natl Acad Sci U S A, 104, 5794-5799.  
17137423 D.L.Bain, A.F.Heneghan, K.D.Connaghan-Jones, and M.T.Miura (2007).
Nuclear receptor structure: implications for function.
  Annu Rev Physiol, 69, 201-220.  
17911242 E.Estébanez-Perpiñá, L.A.Arnold, A.A.Arnold, P.Nguyen, E.D.Rodrigues, E.Mar, R.Bateman, P.Pallai, K.M.Shokat, J.D.Baxter, R.K.Guy, P.Webb, and R.J.Fletterick (2007).
A surface on the androgen receptor that allosterically regulates coactivator binding.
  Proc Natl Acad Sci U S A, 104, 16074-16079.
PDB codes: 2pio 2pip 2piq 2pir 2pit 2piu 2piv 2piw 2pix 2pkl 2qpy
17691075 H.Iwamoto, T.Mizutani, and K.Kano (2007).
Thermodynamics of hydrophobic interactions: entropic recognition of a hydrophobic moiety by poly(ethylene oxide)-zinc porphyrin conjugates.
  Chem Asian J, 2, 1267-1275.  
17721435 K.A.Green, and J.S.Carroll (2007).
Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state.
  Nat Rev Cancer, 7, 713-722.  
17600153 M.R.Calgaro, M.d.e. .O.Neto, A.C.Figueira, M.A.Santos, R.V.Portugal, C.A.Guzzi, D.M.Saidemberg, L.Bleicher, J.Vernal, P.Fernandez, H.Terenzi, M.S.Palma, and I.Polikarpov (2007).
Orphan nuclear receptor NGFI-B forms dimers with nonclassical interface.
  Protein Sci, 16, 1762-1772.  
17284330 Y.E.Timsit, and M.Negishi (2007).
CAR and PXR: the xenobiotic-sensing receptors.
  Steroids, 72, 231-246.  
17001712 L.Toschi, J.Hilbig, T.Wintermantel, A.Engelhaupt, A.Walter, K.H.Fritzemeier, and A.Hillisch (2006).
Protein-structure-based prediction of animal model suitability for pharmacodynamic studies of subtype-selective estrogens.
  ChemMedChem, 1, 1237-1248.  
16914190 P.Ascenzi, A.Bocedi, and M.Marino (2006).
Structure-function relationship of estrogen receptor alpha and beta: impact on human health.
  Mol Aspects Med, 27, 299-402.  
16489580 P.D.Darbre (2006).
Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast.
  J Appl Toxicol, 26, 191-197.  
16633364 Y.Shang (2006).
Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.
  Nat Rev Cancer, 6, 360-368.  
16782818 Y.Wang, N.Y.Chirgadze, S.L.Briggs, S.Khan, E.V.Jensen, and T.P.Burris (2006).
A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta.
  Proc Natl Acad Sci U S A, 103, 9908-9911.
PDB code: 2fsz
16129672 C.E.Bohl, D.D.Miller, J.Chen, C.E.Bell, and J.T.Dalton (2005).
Structural basis for accommodation of nonsteroidal ligands in the androgen receptor.
  J Biol Chem, 280, 37747-37754.
PDB codes: 2ax6 2ax7 2ax8 2ax9 2axa
15521089 K.Fukuzawa, K.Kitaura, M.Uebayasi, K.Nakata, T.Kaminuma, and T.Nakano (2005).
Ab initio quantum mechanical study of the binding energies of human estrogen receptor alpha with its ligands: an application of fragment molecular orbital method.
  J Comput Chem, 26, 1.  
15770646 S.Yoon, A.Smellie, D.Hartsough, and A.Filikov (2005).
Computational identification of proteins for selectivity assays.
  Proteins, 59, 434-443.  
15057969 A.E.Carpenter, A.Ashouri, and A.S.Belmont (2004).
Automated microscopy identifies estrogen receptor subdomains with large-scale chromatin structure unfolding activity.
  Cytometry A, 58, 157-166.  
14977406 M.L.Privalsky (2004).
The role of corepressors in transcriptional regulation by nuclear hormone receptors.
  Annu Rev Physiol, 66, 315-360.  
15300835 S.Top, A.Vessières, P.Pigeon, M.N.Rager, M.Huché, E.Salomon, C.Cabestaing, J.Vaissermann, and G.Jaouen (2004).
Selective estrogen-receptor modulators (SERMs) in the cyclopentadienylrhenium tricarbonyl series: synthesis and biological behaviour.
  Chembiochem, 5, 1104-1113.  
12536206 B.C.Kallenberger, J.D.Love, V.K.Chatterjee, and J.W.Schwabe (2003).
A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease.
  Nat Struct Biol, 10, 136-140.  
  14644319 D.Anderson, T.E.Schmid, A.Baumgartner, E.Cemeli-Carratala, M.H.Brinkworth, and J.M.Wood (2003).
Oestrogenic compounds and oxidative stress (in human sperm and lymphocytes in the Comet assay).
  Mutat Res, 544, 173-178.  
12491500 E.Diamanti-Kandarakis, G.P.Sykiotis, and A.G.Papavassiliou (2003).
Selective modulation of postmenopausal women: cutting the Gordian knot of hormone replacement therapy with breast carcinoma.
  Cancer, 97, 12-20.  
  12676613 H.Tamura, H.Yoshikawa, K.W.Gaido, S.M.Ross, R.K.DeLisle, W.J.Welsh, and A.M.Richard (2003).
Interaction of organophosphate pesticides and related compounds with the androgen receptor.
  Environ Health Perspect, 111, 545-552.  
12794859 N.Foy, E.Stéphan, A.Vessières, E.Salomon, J.M.Heldt, M.Huché, and G.Jaouen (2003).
Synthesis, receptor binding, molecular modeling, and proliferative assays of a series of 17alpha-arylestradiols.
  Chembiochem, 4, 494-503.  
12616628 T.Mordasini, A.Curioni, R.Bursi, and W.Andreoni (2003).
The binding mode of progesterone to its receptor deduced from molecular dynamics simulations.
  Chembiochem, 4, 155-161.  
12663754 X.Wang, X.Qian, H.C.Guo, and J.Hu (2003).
Heat shock protein 90-independent activation of truncated hepadnavirus reverse transcriptase.
  J Virol, 77, 4471-4480.  
11818562 A.Koide, S.Abbatiello, L.Rothgery, and S.Koide (2002).
Probing protein conformational changes in living cells by using designer binding proteins: application to the estrogen receptor.
  Proc Natl Acad Sci U S A, 99, 1253-1258.  
11963993 A.Ohno, M.Shimizu, and S.Yamada (2002).
Fluorinated vitamin D analogs to probe the conformation of vitamin D in its receptor complex: 19F-NMR studies and biological activity.
  Chem Pharm Bull (Tokyo), 50, 475-483.  
  12123286 L.L.Hart, and J.R.Davie (2002).
The estrogen receptor: more than the average transcription factor.
  Biochem Cell Biol, 80, 335-341.  
12180985 M.Hentschke, U.Süsens, and U.Borgmeyer (2002).
Domains of ERRgamma that mediate homodimerization and interaction with factors stimulating DNA binding.
  Eur J Biochem, 269, 4086-4097.  
12077320 R.L.Rich, L.R.Hoth, K.F.Geoghegan, T.A.Brown, P.K.LeMotte, S.P.Simons, P.Hensley, and D.G.Myszka (2002).
Kinetic analysis of estrogen receptor/ligand interactions.
  Proc Natl Acad Sci U S A, 99, 8562-8567.  
12142447 S.H.McLaughlin, and S.E.Jackson (2002).
Folding and stability of the ligand-binding domain of the glucocorticoid receptor.
  Protein Sci, 11, 1926-1936.  
12111992 X.Gu (2002).
Helix 12 in the human estrogen receptor (hER) is essential for the hER function by overcoming nucleosome repression in yeast.
  J Cell Biochem, 86, 224-238.  
  12113800 Y.B.Shi, J.W.Ritchie, and P.M.Taylor (2002).
Complex regulation of thyroid hormone action: multiple opportunities for pharmacological intervention.
  Pharmacol Ther, 94, 235-251.  
  11250199 A.C.Pike, A.M.Brzozowski, J.Walton, R.E.Hubbard, A.G.Thorsell, Y.L.Li, J.A.Gustafsson, and M.Carlquist (2001).
Structural insights into the mode of action of a pure antiestrogen.
  Structure, 9, 145-153.
PDB code: 1hj1
11452016 C.M.Klinge (2001).
Estrogen receptor interaction with estrogen response elements.
  Nucleic Acids Res, 29, 2905-2919.  
11306082 D.Ghosh, and P.Vihko (2001).
Molecular mechanisms of estrogen recognition and 17-keto reduction by human 17beta-hydroxysteroid dehydrogenase 1.
  Chem Biol Interact, 130, 637-650.  
11283262 I.Zelko, T.Sueyoshi, T.Kawamoto, R.Moore, and M.Negishi (2001).
The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver.
  Mol Cell Biol, 21, 2838-2846.  
11154266 J.G.Savory, G.G.Préfontaine, C.Lamprecht, M.Liao, R.F.Walther, Y.A.Lefebvre, and R.J.Haché (2001).
Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces.
  Mol Cell Biol, 21, 781-793.  
11181953 K.Pettersson, and J.A.Gustafsson (2001).
Role of estrogen receptor beta in estrogen action.
  Annu Rev Physiol, 63, 165-192.  
  11744099 M.Schumacher, R.Guennoun, G.Mercier, F.Désarnaud, P.Lacor, J.Bénavides, B.Ferzaz, F.Robert, and E.E.Baulieu (2001).
Progesterone synthesis and myelin formation in peripheral nerves.
  Brain Res Brain Res Rev, 37, 343-359.  
11380259 N.Greenfield, V.Vijayanathan, T.J.Thomas, M.A.Gallo, and T.Thomas (2001).
Increase in the stability and helical content of estrogen receptor alpha in the presence of the estrogen response element: analysis by circular dichroism spectroscopy.
  Biochemistry, 40, 6646-6652.  
11411516 S.Kobayashi, T.Sugaya, N.Sakata, M.Uebayasi, K.Sameshima, and A.Tanaka (2001).
Prediction of endocrine disruptors based on a new structure-activity relationship for sex and environmental hormones using chemical hardness concept.
  Chem Pharm Bull (Tokyo), 49, 680-688.  
11600716 T.Tsuji, M.Onimaru, and H.Yanagawa (2001).
Random multi-recombinant PCR for the construction of combinatorial protein libraries.
  Nucleic Acids Res, 29, E97.  
11168357 Y.C.Kao, K.R.Korzekwa, C.A.Laughton, and S.Chen (2001).
Evaluation of the mechanism of aromatase cytochrome P450. A site-directed mutagenesis study.
  Eur J Biochem, 268, 243-251.  
11325590 Y.Endo, T.Iijima, Y.Yamakoshi, H.Fukasawa, C.Miyaura, M.Inada, A.Kubo, and A.Itai (2001).
Potent estrogen agonists based on carborane as a hydrophobic skeletal structure. A new medicinal application of boron clusters.
  Chem Biol, 8, 341-355.  
11358696 Y.Shi, and J.T.Koh (2001).
Selective regulation of gene expression by an orthogonal estrogen receptor-ligand pair created by polar-group exchange.
  Chem Biol, 8, 501-510.  
10967555 A.Stoica, E.Pentecost, and M.B.Martin (2000).
Effects of selenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells.
  J Cell Biochem, 79, 282-292.  
10760050 C.Hellal-Levy, J.Fagart, A.Souque, and M.E.Rafestin-Oblin (2000).
Mechanistic aspects of mineralocorticoid receptor activation.
  Kidney Int, 57, 1250-1255.  
10760049 D.B.Defranco (2000).
Role of molecular chaperones in subnuclear trafficking of glucocorticoid receptors.
  Kidney Int, 57, 1241-1249.  
10736263 D.F.Smith (2000).
Chaperones in progesterone receptor complexes.
  Semin Cell Dev Biol, 11, 45-52.  
  10711573 E.L.Yong, J.Lim, W.Qi, V.Ong, and A.Mifsud (2000).
Molecular basis of androgen receptor diseases.
  Ann Med, 32, 15-22.  
10675319 I.Grishkovskaya, G.V.Avvakumov, G.Sklenar, D.Dales, G.L.Hammond, and Y.A.Muller (2000).
Crystal structure of human sex hormone-binding globulin: steroid transport by a laminin G-like domain.
  EMBO J, 19, 504-512.
PDB code: 1d2s
  10892801 J.M.Wurtz, B.Guillot, J.Fagart, D.Moras, K.Tietjen, and M.Schindler (2000).
A new model for 20-hydroxyecdysone and dibenzoylhydrazine binding: a homology modeling and docking approach.
  Protein Sci, 9, 1073-1084.  
11701624 J.W.Thornton, and R.DeSalle (2000).
Gene family evolution and homology: genomics meets phylogenetics.
  Annu Rev Genomics Hum Genet, 1, 41-73.  
10677485 K.Yamamoto, H.Masuno, M.Choi, K.Nakashima, T.Taga, H.Ooizumi, K.Umesono, W.Sicinska, J.VanHooke, H.F.DeLuca, and S.Yamada (2000).
Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain.
  Proc Natl Acad Sci U S A, 97, 1467-1472.  
11005855 M.B.Hawkins, J.W.Thornton, D.Crews, J.K.Skipper, A.Dotte, and P.Thomas (2000).
Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts.
  Proc Natl Acad Sci U S A, 97, 10751-10756.  
11250728 M.Ruff, M.Gangloff, J.M.Wurtz, and D.Moras (2000).
Estrogen receptor transcription and transactivation: Structure-function relationship in DNA- and ligand-binding domains of estrogen receptors.
  Breast Cancer Res, 2, 353-359.  
11015194 N.Swamy, W.Xu, N.Paz, J.C.Hsieh, M.R.Haussler, G.J.Maalouf, S.C.Mohr, and R.Ray (2000).
Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
  Biochemistry, 39, 12162-12171.  
10805730 S.F.Wang, S.Ayer, W.A.Segraves, D.R.Williams, and A.S.Raikhel (2000).
Molecular determinants of differential ligand sensitivities of insect ecdysteroid receptors.
  Mol Cell Biol, 20, 3870-3879.  
  11050318 W.Bourguet, P.Germain, and H.Gronemeyer (2000).
Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications.
  Trends Pharmacol Sci, 21, 381-388.  
10469641 A.C.Pike, A.M.Brzozowski, R.E.Hubbard, T.Bonn, A.G.Thorsell, O.Engström, J.Ljunggren, J.A.Gustafsson, and M.Carlquist (1999).
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist.
  EMBO J, 18, 4608-4618.
PDB codes: 1qkm 1qkn
10600690 A.Mueller-Fahrnow, and U.Egner (1999).
Ligand-binding domain of estrogen receptors.
  Curr Opin Biotechnol, 10, 550-556.  
10412035 A.W.Norman, D.Adams, E.D.Collins, W.H.Okamura, and R.J.Fletterick (1999).
Three-dimensional model of the ligand binding domain of the nuclear receptor for 1alpha,25-dihydroxy-vitamin D(3).
  J Cell Biochem, 74, 323-333.  
9876133 D.Kosztin, S.Izrailev, and K.Schulten (1999).
Unbinding of retinoic acid from its receptor studied by steered molecular dynamics.
  Biophys J, 76, 188-197.  
  10481160 D.P.McDonnell (1999).
The Molecular Pharmacology of SERMs.
  Trends Endocrinol Metab, 10, 301-311.  
9894009 F.F.Moebius, K.E.Soellner, B.Fiechtner, C.W.Huck, G.Bonn, and H.Glossmann (1999).
Histidine77, glutamic acid81, glutamic acid123, threonine126, asparagine194, and tryptophan197 of the human emopamil binding protein are required for in vivo sterol delta 8-delta 7 isomerization.
  Biochemistry, 38, 1119-1127.  
10359561 F.J.Ghadessy, J.Lim, A.A.Abdullah, V.Panet-Raymond, C.K.Choo, R.Lumbroso, T.G.Tut, B.Gottlieb, L.Pinsky, M.A.Trifiro, and E.L.Yong (1999).
Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions.
  J Clin Invest, 103, 1517-1525.  
11233142 H.Tanaka, Y.Makino, K.Okamoto, T.Iida, K.Yan, and N.Yoshikawa (1999).
Redox regulation of the glucocorticoid receptor.
  Antioxid Redox Signal, 1, 403-423.  
10418126 I.J.McEwan (1999).
Investigation of steroid receptor function in the budding yeast Saccharomyces cerevisiae.
  FEMS Microbiol Lett, 176, 1-9.  
  10454590 J.Zhang, X.Hu, and M.A.Lazar (1999).
A novel role for helix 12 of retinoid X receptor in regulating repression.
  Mol Cell Biol, 19, 6448-6457.  
  10567540 L.A.Sheldon, C.L.Smith, J.E.Bodwell, A.U.Munck, and G.L.Hager (1999).
A ligand binding domain mutation in the mouse glucocorticoid receptor functionally links chromatin remodeling and transcription initiation.
  Mol Cell Biol, 19, 8146-8157.  
10872460 R.V.Weatherman, R.J.Fletterick, and T.S.Scanlan (1999).
Nuclear-receptor ligands and ligand-binding domains.
  Annu Rev Biochem, 68, 559-581.  
10555957 S.Aliau, H.Mattras, E.Richard, and J.L.Borgna (1999).
Cysteine 530 of the human estrogen receptor alpha is the main covalent attachment site of 11beta-(aziridinylalkoxyphenyl)estradiols.
  Biochemistry, 38, 14752-14762.  
9915825 S.H.Hong, and M.L.Privalsky (1999).
Retinoid isomers differ in the ability to induce release of SMRT corepressor from retinoic acid receptor-alpha.
  J Biol Chem, 274, 2885-2892.  
9875847 A.K.Shiau, D.Barstad, P.M.Loria, L.Cheng, P.J.Kushner, D.A.Agard, and G.L.Greene (1998).
The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.
  Cell, 95, 927-937.
PDB codes: 2erd 2ert 3erd 3ert
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.